Determinants of graft clarity in penetrating kerotoplasty

Archives of Ophthalmology
R L Abbott, R K Forster

Abstract

A total of 240 consecutive penetrating keratoplasties with a minimum six months' follow-up were examined to determine the influence of preoperative prognosis, donor age, death-enucleation time, death-surgery time, and surgical experience on graft clarity. Graft results, classified as clear, nebulous, or edematous, were compared within two prognostic categories in aphakic, combined, and phakic keratoplasty groups. Preoperative prognostic groups and surgical experience appeared to be most important in affecting graft clarity, whereas the donor age, death-enucleation time, and death-surgery time seemed to have little effect.

Citations

Mar 1, 1991·The British Journal of Ophthalmology·K W Sharif, T A Casey
Mar 10, 2001·Ophthalmology·V BersudskyS Rumelt
Apr 1, 1997·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·A C Sobottka VenturaK Engelmann
Aug 1, 1981·Ophthalmology·J G LinnG M Marsh
Nov 1, 1993·Ophthalmology·H M BoisjolyR Roy
Jun 1, 1982·Ophthalmology·P G PaglenR G Webster
Apr 5, 2008·Ophthalmology·UNKNOWN Cornea Donor Study Investigator GroupDavid D Verdier
Jan 1, 1989·Survey of Ophthalmology·S E Wilson, W M Bourne
Jan 1, 1987·Journal of Cataract and Refractive Surgery·M I Roat, D A Hiles
Jun 13, 2001·Acta Ophthalmologica Scandinavica·K InoueT Tsuru
Jun 1, 1984·Acta Ophthalmologica·T OlsenE Favini
Jun 1, 1987·Acta Ophthalmologica·J Andersen, N Ehlers

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.